2019 Conference Evaluation Form

News


2019 Conference provides 6CPD Credits - in accordance with the CPD Scheme of the Royal College of Radiologists


2019 Presentations Available HERE


2019 Programme Now Available HERE


2019 Conference Evaluation Form Available HERE


2019 Conference Abstracts Available HERE


2019 Conference Sponsors Below


Platinum Sponsor
BXTAccelyon Logo

Silver Sponsors
Augmenix logo logo
BD and BARD logo
Eckert and Ziegler Logo
Elekta Company Logo

Bronze Sponsors
Bayer logo
Mermaid Medical small logo
Oncology Imaging Systems logo
SeeDos logo
Varian medical systems logo

Additional Sponsor
BK Medical ultrasound systems logo
 
 
 
 

2019 Prostate Brachytherapy Conference Evaluation Questionnaire

 

Many thanks for your attendance at the 2019 meeting. To enable us to process your certificate of attendance and to plan future meetings, please complete the following questionnaire.

 

1. About You - NB * are required fields
* Name:
* Position:
* Medical Establishment:
* Email:
* Postcode:
* GMC No: (if not applicable type N/A)
2. About the Meeting

Learning Objectives

 

In relation to brachytherapy for prostate cancer, participants will:

 

1. Understand the relative benefits of monotherapy.

2. Be informed of different approaches to managing intermediate and high risk prostate cancer.

3. Actively participate in discussions on salvage options post brachytherapy.

 

Please click the relevant boxes.
1. To what extent do you feel the meeting helped you to achieve the above learning outcomes?
Not at all 1 2 3 4 5 Completely
   
 
Please click the relevant boxes.
2. How would you rate the overall educational value of the meeting?
Poor 1 2 3 4 5 Excellent
   
 
3. Did the event meet with your expectations?
  Yes:   No:  
 
If no, please state why not.
 
3. How would you rate the educational value of each session?
Molecular Imaging in Prostate Cancer – Current Status and Future Prospects
Poor 1 2 3 4 5 Excellent
   
 
Biofocussed prostate cancer Radiotherapy (BiRT)
Poor 1 2 3 4 5 Excellent
   
 
Optimal fractionation in HDR brachytherapy
Poor 1 2 3 4 5 Excellent
   
 
Minimising and managing morbidity in LDR brachytherapy
Poor 1 2 3 4 5 Excellent
   
 
Patient contamination in prostate LDR brachytherapy
Poor 1 2 3 4 5 Excellent
   
 
Proffered papers - Clinical
Poor 1 2 3 4 5 Excellent
   
 

Breakout Sessions - Physics: Verification/Uncertainties Theme

Differences in dosimetry, planning and equieffective doses for prostate brachytherapy
Poor 1 2 3 4 5 Excellent
   
In-vivo dosimetry in clinical practice
Poor 1 2 3 4 5 Excellent
   
 
Proffered papers - Physics
Poor 1 2 3 4 5 Excellent
   
 

Breakout Sessions - Clinical: Toxicity Theme

Screening for and managing radiation bowel toxicity
Poor 1 2 3 4 5 Excellent
   
 
Medical management of sexual dysfunction
Poor 1 2 3 4 5 Excellent
   
 
Management of psycho-sexual dysfunction after prostate cancer treatment
Poor 1 2 3 4 5 Excellent
   

Main Conference Continued...

Debate: Which is best: LDR or HDR boosting when combining with EBRT?
Poor 1 2 3 4 5 Excellent
   
 
4. Please rate the value of the meeting in terms of:
   a. Learning new information
Poor 1 2 3 4 5 Excellent
   
 
   b. Sharing best practice
Poor 1 2 3 4 5 Excellent
   
 
   c. Networking opportunity  
Poor 1 2 3 4 5 Excellent
   
 
   d. To what extent do you feel that this meeting will help you to improve your clinical practice?
Poor 1 2 3 4 5 Excellent
   
 
5. Please provide comments/suggestions for topics to include in future meetings or activities

Many thanks for your time